News
Press ReleaseKing's College London spins out Korecyte Bio Ltd with investment and support from Cell and Gene Therapy Catapult to advance novel CAR-T platform for solid tumours
Celebrating the achievements of the Advanced Therapies Apprenticeship CommunityPress Release: CGT Catapult appoints two new Board membersPress Release: Stevenage named High Potential Opportunity zone for Cell and Gene TherapyRegulatory News - September 2020Press Release: CGT Catapult appoints Dr Nick Johnson as Chief Strategy and Impact OfficerPress release: CombiGene and CGT Catapult collaboration completes development of quality control analytical assays for clinical production of CombiGene’s AAV-based gene therapy for the treatment of epilepsyAdvanced Therapy Treatment Centre network awarded £9.5m further investmentJuly/August news: Large-scale manufacturing innovationRegulatory news - August 2020Press release: Autolus Therapeutics to further expand operations at the CGT Catapult manufacturing centre to enable commercial manufacture of CAR-T cell therapiesRegulatory news - July 2020Press release: CGT Catapult appoints Dr Sharon Brownlow as Chief Business Officer
